Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease (2017)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; ULRICH, ALEXANDER HENNING - IQ
- Unidades: ICB; IQ
- DOI: 10.3727/096368917X695227
- Subjects: DOENÇA DE PARKINSON; ESTRESSE OXIDATIVO; RECEPTORES DOPAMINÉRGICOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cell Transplantation
- ISSN: 0963-6897
- Volume/Número/Paginação/Ano: v. 26, n. 4, p. 669-677, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
FERRAZOLI, Enéas Galdini et al. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease. Cell Transplantation, v. 26, n. 4, p. 669-677, 2017Tradução . . Disponível em: https://doi.org/10.3727/096368917X695227. Acesso em: 11 maio 2024. -
APA
Ferrazoli, E. G., Souza, H. D. N. de, Nascimento, I. C. do, Giacomelli, Á. O., Schwindt, T. T., Britto, L. R. G. de, & Ulrich, H. (2017). Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease. Cell Transplantation, 26( 4), 669-677. doi:10.3727/096368917X695227 -
NLM
Ferrazoli EG, Souza HDN de, Nascimento IC do, Giacomelli ÁO, Schwindt TT, Britto LRG de, Ulrich H. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease [Internet]. Cell Transplantation. 2017 ; 26( 4): 669-677.[citado 2024 maio 11 ] Available from: https://doi.org/10.3727/096368917X695227 -
Vancouver
Ferrazoli EG, Souza HDN de, Nascimento IC do, Giacomelli ÁO, Schwindt TT, Britto LRG de, Ulrich H. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease [Internet]. Cell Transplantation. 2017 ; 26( 4): 669-677.[citado 2024 maio 11 ] Available from: https://doi.org/10.3727/096368917X695227 - P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation
- Mechanism of acetylcholine-induced calcium signaling, proliferation and differentiation effects during In vitro neuronal differentiation of embryonal cells
- Carvacrol promotes neuroprotection in the mouse hemiparkinsonian model
- Expression and activity of nicotinic and muscarinic acetylcholine receptors during neuronal differentiation In vitro
- Neuronal cell fate determination in P19 embryonic carcinoma cells is dependent on spontaneous calcium oscillations
- Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells
- Proliferation and differentiation of embryonic cells to neurons depende on purinergic receptor-induced calcium transients
- Mechanism of acetylcholine-induced calcium signaling during neuronal differentiation of P19 embryonal carcinoma cells In vitro
- Pharmachological properties and proliferation-inducing effects of purinergic receptors in P19 embryonal cells as In vitro model for neuronal differentiation
- New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders
Informações sobre o DOI: 10.3727/096368917X695227 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
